Cost of borderline personality disorder in Catalonia (Spain)

作者: L. Salvador-Carulla , M. Bendeck , M. Ferrer , Ó. Andión , E. Aragonès

DOI: 10.1016/J.EURPSY.2014.07.001

关键词: Sick leaveMedicineMental healthOccupational safety and healthPsychiatryPoison controlHealth economicsTotal costBorderline personality disorderIndirect costs

摘要: Abstract Introduction The available information on the cost of illness Borderline Personality Disorder (BPD) is overtly insufficient for policy planning. Our aim was to estimate costs BPD in Catalonia (Spain) 2006. Methods This a multilevel cross-design synthesis study combining qualitative nominal approach, quantitative ‘top-down’ analysis multiple health databases, and ‘bottom-up’ data local surveys. Both direct indirect have been estimated from governmental societal perspective. Results Estimated year-prevalence 0.7% (41,921 cases), but only 9.6% these cases were treated mental system (4033 cases). baseline total 45.6 million €, which 15.8 million € (34.7%) related care. distribution 0.4% primary care; 4% outpatient 4.7% hospitalisation; emergency 24.9% pharmacotherapy. Additionally, drug addiction treatment persons with 11.2%; associated sheltered employment 23.9% those crime justice 9.7%. Indirect – including temporary sick leave premature death (suicide) – represented 20.5% costs. average annual per patient 11,308 €. Conclusions An under-reporting identified by experts all databases official registries. Most not Amongst categories, pharmacotherapy had largest proportion despite lack specificity BPD. reinforces idea complexity an inadequate inefficient use resources.

参考文章(47)
Marta Torrens, Gail Gilchrist, Antonia Domingo-Salvany, Psychiatric comorbidity in illicit drug users: Substance-induced versus independent disorders Drug and Alcohol Dependence. ,vol. 113, pp. 147- 156 ,(2011) , 10.1016/J.DRUGALCDEP.2010.07.013
Anna García-Altés, Josep Ma Ollé, Fernando Antoñanzas, Joan Colom, The social cost of illegal drug consumption in Spain Addiction. ,vol. 97, pp. 1145- 1153 ,(2002) , 10.1046/J.1360-0443.2002.00170.X
Ann MacPhail, Nominal Group Technique: A useful method for working with young people British Educational Research Journal. ,vol. 27, pp. 161- 170 ,(2001) , 10.1080/01411920120037117
Elfrida Hartveit Kvarstein, Espen Arnevik, Vidar Halsteinli, Frida Gullestad Rø, Sigmund Karterud, Theresa Wilberg, Health service costs and clinical gains of psychotherapy for personality disorders: a randomized controlled trial of day-hospital-based step-down treatment versus outpatient treatment at a specialist practice. BMC Psychiatry. ,vol. 13, pp. 315- 315 ,(2013) , 10.1186/1471-244X-13-315
Joan Rovira, Guillermina Albarracin, Luis Salvador, Javier Rejas, Eduardo Sánchez-Iriso, Juan M. Cabasés, The Cost of Generalized Anxiety Disorder in Primary Care Settings: Results of the ANCORA Study Community Mental Health Journal. ,vol. 48, pp. 372- 383 ,(2012) , 10.1007/S10597-012-9503-4
L. Salvador-Carulla, J. M. Haro, J. Cabasés, V. Madoz, J. A. Sacristán, J. L. Vázquez-Barquero, Service utilization and costs of first‐onset schizophrenia in two widely differing health service areas in North‐East Spain Acta Psychiatrica Scandinavica. ,vol. 100, pp. 335- 343 ,(2007) , 10.1111/J.1600-0447.1999.TB10876.X
Mary C. Zanarini, Frances R. Frankenburg, John Hennen, D. Bradford Reich, Kenneth R. Silk, The McLean Study of Adult Development (MSAD): Overview and implications of the first six years of prospective follow-up Journal of Personality Disorders. ,vol. 19, pp. 505- 523 ,(2005) , 10.1521/PEDI.2005.19.5.505
Antonia S. New, David M. Carpenter, M. Mercedes Perez-Rodriguez, Luis H. Ripoll, Jennifer Avedon, Uday Patil, Erin A. Hazlett, Marianne Goodman, Developmental differences in diffusion tensor imaging parameters in borderline personality disorder. Journal of Psychiatric Research. ,vol. 47, pp. 1101- 1109 ,(2013) , 10.1016/J.JPSYCHIRES.2013.03.021
Juan C. Pascual, Ana Martín-Blanco, Joaquim Soler, Alicia Ferrer, Thais Tiana, Enrique Alvarez, Víctor Pérez, A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines. International Clinical Psychopharmacology. ,vol. 25, pp. 349- 355 ,(2010) , 10.1097/YIC.0B013E32833E23ED